Trialect

Active

Molecular Cardiology and Cardiac Regeneration in Heart Failure

Baylor College of Medicine

Dr. Tamer M. A. Mohamed is an Associate Professor and Director of Cardiac Regeneration at Baylor College of Medicine, with extensive expertise in molecular cardiology, cardiac physiology, and translational therapeutics. He received his Ph.D. in Molecular Cardiology from the University of Manchester and completed advanced postdoctoral training in cardiac signaling, regeneration, and epigenetics at leading institutions, including the Gladstone Institutes, University of California, San Francisco. His research focuses on elucidating mechanisms of cardiac hypertrophy and heart failure, with a strong emphasis on developing innovative regenerative therapies such as cardiomyocyte proliferation and direct cardiac reprogramming. Dr. Mohamed has played a key role in advancing gene therapy approaches and translational cardiac models, including precision-cut human heart slices for drug testing and disease modeling. His work bridges basic science and clinical application, contributing to novel therapeutic strategies aimed at repairing the injured heart and improving outcomes in cardiovascular disease.

Dr. Tamer M. A. Mohamed is a faculty member at Baylor College of Medicine. He conducts this training program in his personal capacity and not as a representative of, or on behalf of, Baylor College of Medicine.

Programs will be conducted during the following periods: May–June; September–October; February–March.

Main Areas of Interest

Molecular Biology
Cardiac physiology
Heart Failure
Precision-cut heart slices

Specialties

Cardiothoracic Surgery

Cardiovascular Diseases

Molecular Biology

Cell Biology

Techniques You Will Learn

Molecular cardiology techniques (gene expression, signaling pathways in cardiac hypertrophy and heart failure)
Cardiac regeneration strategies (cardiomyocyte proliferation, direct cardiac reprogramming)
Precision-cut heart slice models for functional and translational cardiac research
Preclinical drug testing and gene therapy approaches in heart failure
Cardiac physiology and disease modeling using human and animal tissue systems

Modules

Fundamentals of Cardiac Physiology & Molecular Mechanisms

Overview of cardiac function and heart failure
Key molecular pathways in cardiac hypertrophy and dysfunction

Cardiac Regeneration & Cardiomyocyte Proliferation

Mechanisms of cardiac regeneration
Cell cycle regulation and reprogramming approaches

Precision-Cut Heart Slices & Translational Models

Introduction to heart slice technology
Applications in disease modeling and functional assessment

Translational Therapeutics & Drug/Gene Therapy

Preclinical drug screening and validation
Gene therapy strategies for heart failure

Program Fee


Total Number of Modules	4
Time duration of Each module	30 minutes
Total Program Cost	$500

Who Can Apply

MD, PhD, or MD/PhD candidates
Postdoctoral researchers and early-career scientists
Cardiology fellows and residents with research interest
Biomedical, biotechnology, or life sciences graduates (Master’s level or above)
Clinician-scientists and academic faculty seeking to expand expertise in cardiac regeneration

Host Details

Host Name: Tamer Mahmoud Abdelfattah Mohamed

Affiliation: Baylor College of Medicine

Address: Department of Surgery Baylor College of Medicine Texas Heart Institute 6770 Bertner Avenue, Houston, TX 77030

Website URL:

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.